Nation & World Glance
FDA allows 1st rapid virus test that gives results at home
WASHINGTON – U.S. regulators on Tuesday allowed emergency use of the first rapid coronavirus test that can be performed and developed entirely at home.
The announcement by the Food and Drug Administration represents an important step in U.S. efforts to expand testing options for COVID-19 beyond health care facilities and testing sites. However, the test will require a prescription, likely limiting its initial use.
The FDA granted emergency authorization to the 30-minute test kit from Lucira Health, a California manufacturer.
The company’s test allows users to swab themselves to collect a nasal sample. The sample is then swirled in a vial that plugs into a portable device, that interprets the results and displays whether the person tested positive or negative for coronavirus.
To date, the agency has authorized nearly 300 tests for coronavirus. The vast majority require a nasal swab performed by a health professional and must be processed at laboratories using high-tech testing equipment. A handful allow people to collect their own sample at home – a nasal swab or saliva – that’s then shipped to a lab, which usually means waiting days for results.
Sen. Grassley, 87, says he tested positive for coronavirus
WASHINGTON – Iowa Sen. Chuck Grassley, the longest-serving Republican senator and third in the line of presidential succession, said Tuesday that he has tested positive for the coronavirus.
Grassley, 87, had announced earlier Tuesday that he was quarantining after being exposed to the virus and was waiting for test results. On Tuesday evening, he tweeted that he had tested positive.
“I’ll b following my doctors’ orders/CDC guidelines & continue to quarantine. I’m feeling good + will keep up on my work for the ppl of Iowa from home,” he tweeted.
The Iowa Republican, who was in the Senate and voting on Monday, did not say how he had been exposed. His office said that he was not experiencing any symptoms.
Controversial Fed nominee Shelton stalls in Senate test vote
WASHINGTON — The nomination of Judy Shelton, President Donald Trump’s controversial pick for the Federal Reserve, is stalled in the Senate after Vice President-elect Kamala Harris returned to the chamber to cast a key vote in a tally Tuesday.
Two key Republicans were absent because of COVID-related concerns. The 47-50 vote came as the Republican-controlled Senate continues to focus its energies in the post-election lame-duck session on confirming Trump’s appointees. Shelton is an unusually caustic critic of the Fed and was opposed by two GOP senators, Susan Collins of Maine and Mitt Romney of Utah, in Tuesday’s vote. Harris has been focused on the transition to the Biden administration but returned to the chamber for her first vote since winning the vice presidency.
Senator-elect Mark Kelly, D-Ariz., is likely to join the Senate when the chamber returns from its Thanksgiving break. That could leave Shelton short of support for confirmation even if Majority Leader Mitch McConnell, R-Ky., seeks a revote next month